Federal court rejects drugmaker’s efforts to end lawsuit claiming they delayed more effective HIV treatment for more expensive, less effective drug

ELURA NANOS | Jan 15th, 2024 A California appeals court has ruled that a pharmaceutical company can be held legally responsible for slow-walking the sale of an effective AIDS drug, because its decision may have been made solely to maximize its own profits. In a first-of-its-kind ruling, the California First District Court of Appeals in San Francisco ruled Tuesday that pharma giant Gilead Life Sciences can … Read More